← Back to ELDN

Eledon Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
−$32−$39−$17−$11−$6.5$77−$45−$24
−$0.27−$0.33−$0.21−$0.13−$0.08−$0.28−$0.92−$0.65
114112777777554230

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.